AZD2115 Single Ascending Dose Study
NCT01283984 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 96
Last updated 2011-08-18
Summary
AZD2115 Single Ascending Dose Study
Conditions
- Chronic Obstructive Pulmonary Disease
- Lung Disease Causing Persistent Narrowing of the Airways
Interventions
- DRUG
-
AZD2115
Single dose, oral inhalation (nebuliser solution)
- DRUG
-
Single dose, oral inhalation (nebuliser solution)
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2011-08-31
- Completion
- 2011-08-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00758459 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Subjects
NCT02814656 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy
NCT02238483 ·Status: COMPLETED ·Phase: PHASE2
-
The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01205269 ·Status: COMPLETED ·Phase: PHASE2
-
To Assess the Safety, Tolerability, and Pharmacokinetics of AZD7624 in Healthy Volunteers and COPD Patients
NCT01817855 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase IIa Study Assessing the Effects of AZD1236 on Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00758706 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate Safety, Tolerability and Effect of Multiple Dosing With AZD 4721 and/or With AZD 5069
NCT01962935 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871
NCT02971293 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men
NCT02645253 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT01708057 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy Male Japanese Subjects
NCT03159442 ·Status: COMPLETED ·Phase: PHASE1
-
Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol
NCT01555099 ·Status: COMPLETED ·Phase: PHASE2
-
A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases.
NCT03645434 ·Status: COMPLETED ·Phase: PHASE2
-
A Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Subjects and in Patients With Chronic Obstructive Pulmonary Disease
NCT01016951 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis
NCT01255592 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Two Dose Levels of AZD2115 in Subjects With Moderate to Severe COPD
NCT02109406 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT00690482 ·Status: COMPLETED ·Phase: PHASE2
-
Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT00629239 ·Status: COMPLETED ·Phase: PHASE2
-
A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT01233232 ·Status: COMPLETED ·Phase: PHASE2
-
Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects
NCT02573155 ·Status: COMPLETED ·Phase: PHASE1
-
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
NCT06154837 ·Status: RECRUITING ·Phase: PHASE1
-
First Time in Human Study With GSK1325756
NCT01209052 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)
NCT00358436 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00929708 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects
NCT02397005 ·Status: UNKNOWN ·Phase: PHASE1